A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon (Q33512921)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon (English)

1 reference

Europe PubMed Central

27 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

Peter Gottfried Kremsner

16

object named as

Peter G Kremsner

1 reference

Europe PubMed Central

27 July 2017

1

object named as

Bertrand Lell

1 reference

Europe PubMed Central

27 July 2017

W Ripley Ballou

14

object named as

W Ripley Ballou

1 reference

Europe PubMed Central

27 July 2017

6

object named as

Saadou Issifou

1 reference

Europe PubMed Central

27 July 2017

Tonya Villafana

13

object named as

Tonya Villafana

1 reference

Europe PubMed Central

27 July 2017

7

object named as

Johan Vekemans

1 reference

Europe PubMed Central

27 July 2017

9

object named as

Marc Lievens

1 reference

Europe PubMed Central

27 July 2017

Marie-Claude Dubois

10

object named as

Marie-Claude Dubois

1 reference

Europe PubMed Central

27 July 2017

author name string

Selidji Agnandji

2

1 reference

Europe PubMed Central

27 July 2017

Isabelle von Glasenapp

3

1 reference

Europe PubMed Central

27 July 2017

Sonja Haertle

4

1 reference

Europe PubMed Central

27 July 2017

Sunny Oyakhiromen

5

1 reference

Europe PubMed Central

27 July 2017

Amanda Leach

8

1 reference

Europe PubMed Central

27 July 2017

Marie-Ange Demoitie

11

1 reference

Europe PubMed Central

27 July 2017

Terrell Carter

12

1 reference

Europe PubMed Central

27 July 2017

Joe Cohen

15

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

27 October 2009

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

4

1 reference

Europe PubMed Central

27 July 2017

10

1 reference

Europe PubMed Central

27 July 2017

e7611

1 reference

Europe PubMed Central

27 July 2017

copyright license

Creative Commons Attribution 4.0 International

27 October 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Socio-economic status is inversely related to bed net use in Gabon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

A review of human vaccine research and development: malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

The economic and social burden of malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

The role of red blood cell polymorphisms in resistance and susceptibility to malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Acellular pertussis vaccines. Towards an improved safety profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

21 June 2018

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

Progress towards the development of malaria vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

Plasmodium falciparum transmission intensity and infection rates in children in Gabon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

Malaria epidemiology in the province of Moyen Ogoov, Gabon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763199

31 October 2018

Identifiers

10.1371/JOURNAL.PONE.0007611

1 reference

Europe PubMed Central

27 July 2017

2009PLoSO...4.7611L

0 references

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33512921&oldid=2022641032"